Companies · Medical Devices

ReadySet Surgical, Inc.

CLEVELAND · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on ReadySet Surgical, Inc. — recommendation, valuation, rhythm, risks.
$9.9M
Total raised · real
3
Rounds
0.7×
Latest step-up
Top 24%
Sector rank · raised
Series A
Latest stage · inferred · Wed Jul 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

ReadySet Surgical, Inc. looks fair against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.74× the median modeled value of Series A Medical Devices companies in 2025–2027 (10 peers) — value vs value, same stage and era.
  • Within the normal band (74% of peer median) for its niche.
Active
  • Last raise 12 mo ago; this sector typically re-raises about every 16 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

ReadySet Surgical, Inc. is one of 233 Medical Devices companies tracked from CLEVELAND. By capital raised it ranks in the upper tier (ahead of 77% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2025-07-02
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2019-03-15 Raised $4.2M (real) Modeled valuation $100M (est)$4.2M$100MSeries A2019Series A · 2024-06-18 Raised $3.4M (real) Modeled valuation $17M (est)$3.4M$17MSeries A2024Series A · 2025-07-02 Raised $2.3M (real) Modeled valuation $7.6M (est)$2.3M$7.6MSeries A2025+$3.4M+$2.3MCumulative $9.9M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$4.2M · 2019
Series A extension$3.4M · 2024
Series A extension$2.3M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$7.6M
Base estimate est.
$2.8M
Conservative case
$13.0M
Upside case
$10.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Series A · modeled $100.4M · 2019-03-152019Series A · modeled $17.3M · 2024-06-18Series A · modeled $7.6M · 2025-07-022025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
50%
Survival probability
27% low · 68% high
1.49×/yr
Annual markup
1.87×/yr upside case
1.0 yr
Elapsed time used
1.0 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
38 mo
Avg between rounds
$1.6M/yr
Capital velocity
7.3 yr
On record since
2019
First round
3
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.9× above median
This company$9.9M
Sector median$2.6M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.5× of median
This company$2.3M
Sector median$4.6M
Modeled value — vs sector median (estimate, all stages) 0.5× of median
This company$7.6M
Sector median$15.4M

Raised more than 77% of sector peers (real $). Modeled value above 45% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #7 of 10.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Curadel Surgical Innovations, Inc. · Series A Raised $26.0M · modeled $44.1M (est)Gestalt Diagnostics, LLC · Series A Raised $9.6M · modeled $25.2M (est)ClearCut Surgical, Inc. · Series A Raised $4.5M · modeled $15.2M (est)Bayou Surgical, Inc. · Series A Raised $13.2M · modeled $14.8M (est)AI Diagnostics · Series A Raised $5.2M · modeled $12.7M (est)NexEos Diagnostics, Inc. · Series A Raised $25.7M · modeled $7.9M (est)Black Light Surgical, Inc. · Series A Raised $12.9M · modeled $6.9M (est)EDGe Surgical, Inc. · Series A Raised $10.2M · modeled $3.6M (est)Surgical Center of Greensboro, LLC · Series A Raised $12.4M · modeled $2.9M (est)ReadySet Surgical, Inc. (this company) Raised $9.9M · modeled $7.6M (est)ReadySet Surgical, Inc.
CompanyStageRaised · realValue · estvs peer med.
Curadel Surgical Innovations, Inc.Series A$26.0M$44.1M4.27×
Gestalt Diagnostics, LLCSeries A$9.6M$25.2M2.44×
ClearCut Surgical, Inc.Series A$4.5M$15.2M1.47×
Bayou Surgical, Inc.Series A$13.2M$14.8M1.43×
AI DiagnosticsSeries A$5.2M$12.7M1.23×
NexEos Diagnostics, Inc.Series A$25.7M$7.9M0.77×
ReadySet Surgical, Inc. this companySeries A$9.9M$7.6M0.74×
Black Light Surgical, Inc.Series A$12.9M$6.9M0.66×
EDGe Surgical, Inc.Series A$10.2M$3.6M0.35×
Surgical Center of Greensboro, LLCSeries A$12.4M$2.9M0.28×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$4.2M2019-03-15$18.9M$100.4M90%
Series A$3.4M2024-06-18$15.6M$17.3M90%
Series A$2.3M2025-07-02$10.3M$7.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$4.2M2019-03-15
    • First recorded raise — entered as Series A.
    • 16 investors on this round.
  2. Series A$3.4M2024-06-18
    • Raised again after 63 mo — slower than the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 13 investors on this round.
  3. Series A$2.3M2025-07-02
    • Raised 12 mo later, in step with the ~16 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 7 investors on this round.
Intelligence
2028 ~Q3
Modeled next raise · ~38mo cadence
$2.3M
Modeled next size est.range $2.3M$3.6M
0.7×
Last step-up
$1.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Harris19 other2024-06
Hardik Desai4 other2024-06
Kevin Terrasi4 other2024-06
Kevin Von Keyserling2 other2024-06
John O'Neill1 other2024-06
Timothy Chapman1 other2024-06
Brook Von Critchfield2025-07
Hardik Von Desai2025-07
John Von Harris2025-07
Keerthi Kanubaddi2019-03
Kevin Von Terrasi2025-07
Matthew Rechin2024-06
Registry & provenance

ReadySet Surgical, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1771939
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Certified Security Solutions, Inc.CybersecuritySeries A$7.1M$78.8Mnetwork2 shared operators · same stage
Barsa Surgical Inc.Medical DevicesSeries A$10.0M$60.8Msame sector · same stage
Gestalt Diagnostics, LLCMedical DevicesSeries A$9.6M$25.2Msame sector · same stage
EDGe Surgical, Inc.Medical DevicesSeries A$10.2M$3.6Msame sector · same stage
Fulcrum Implant Systems, Inc.Medical DevicesSeries A$10.5M$253.4Msame sector · same stage
Reliant Immune Diagnostics, Inc.Medical DevicesSeries A$10.9M$262.4Msame sector · same stage
SafeOp Surgical, Inc.Medical DevicesSeries A$10.9M$136.4Msame sector · same stage
Surgical Innovation Associates Inc.Medical DevicesSeries A$8.9M$86.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
ClearCut Surgical, Inc.Medical DevicesSeries A$15.2M85%
SafeOp Surgical, Inc.Medical DevicesSeries A$136.4M85%
Prescient Surgical, Inc.Medical DevicesSeries A$3.5M84%
Minerva Surgical IncMedical DevicesSeries B$397.4M84%
Tally Surgical, Inc.Medical DevicesSeries A$38.8M84%
Surgical Innovation Associates Inc.Medical DevicesSeries A$86.9M84%
IC Surgical, Inc.Medical DevicesPre-Seed$5.5M84%
Think Surgical, Inc.Medical DevicesSeries D+$88.5M84%
Frequently asked
How much funding has ReadySet Surgical, Inc. raised?
ReadySet Surgical, Inc. has raised approximately $9.9M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is ReadySet Surgical, Inc.'s estimated valuation?
Provath's modeled valuation for ReadySet Surgical, Inc. is approximately $7.6M (modeled range $2.8M–$13.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is ReadySet Surgical, Inc. at?
ReadySet Surgical, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Jul 02.
What does ReadySet Surgical, Inc. do and where is it based?
ReadySet Surgical, Inc. operates in the Medical Devices sector, based in CLEVELAND.
Explore related

See where ReadySet Surgical, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at ReadySet Surgical, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.